Overview
- 74 inspections across 69 sites are on record.
- 249 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-10-20.
At a glance
Inspections
74
Sites
69
Observations
249
Career since
Nov 2014
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| SCA Pharmaceuticals, LLC | 20 Oct 2023 | Human Drugs | View 483 → |
| Edge Pharmacy Services, LLC | 30 Mar 2020 | Human Drugs | View 483 → |
| MANCHESTER VA MEDICAL CENTER | 27 Jan 2020 | Human Drugs | View 483 → |
| Avista Pharma Solutions, Inc. | 18 Dec 2019 | Human Drugs | View 483 → |
| AbbVie Bioresearch Center | 18 Nov 2019 | Human Drugs |
Sites inspected
SCA Pharmaceuticals, LLCWindsor, United States1 insp.
Edge Pharmacy Services, LLCColchester, United States1 insp.
MANCHESTER VA MEDICAL CENTERManchester, United States1 insp.
Avista Pharma Solutions, Inc.Agawam, United States1 insp.
AbbVie Bioresearch CenterWorcester, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Erik W Koester22 shared
Sean R Marcsisin8 shared
Dien N Nguyen8 shared
Stacey S Degarmo6 shared
Robert J Martin5 shared
Mary-Jeanet Mcgarry4 shared
Jonah S Ufferfilge3 shared
Christopher Janik2 shared
Samir C Gala1 shared
Thomas J Arista1 shared
Full investigator report
Get the verbatim findings behind John P Mistler's 249 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site